Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
13vPnC Vaccine in HIV-Infected Subjects Previously Immunized With 23vPS
NCT00963235Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2009
- Primary completion
- May 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Prevnar 13 in pneumococcal infection, sponsored by Pfizer. Started Nov 2009; status: completed.
02
Drugs
Prevnar 13
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00963235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00963235.